Research & Development

大香蕉网伊人在线4五月婷婷久久大香蕉色综合Karl Lagerfeld逝世后,时尚行业格局变化的…


  當雲瑯,曹襄兩人對坐飲酒的時候,身邊只有曹襄的平妻牛氏在伺候。   劉徹笑道︰“還是說清楚一些比較好。”大香蕉网伊人在线4   殺豬時,病豬的慘叫聲聲震四野,埋羊的時候,羊不會叫喚,只是流淚流的讓人肝腸寸斷。五月婷婷久久大香蕉   卓姬見雲瑯用手把老虎的牙齒摸了一個遍,就有些妒忌的道︰“你待我的時候可沒有這麼上心。”   這種快樂或許是向山上丟了一塊石頭,或許是今天往河水里撒尿的時候水花特別的大。色综合   雲瑯苦笑道︰“因為你母親邀請我在拜見你祖母之前,與她在你家前宅敘話。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo